GlassScriptPhysician profile
Vanessa Levine
NPI 1114483906
$3,914.38
in general payments reported to CMS, 2019-2025
20 companies · $97.05 in 2025
The $97.05 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $492 · 2022: $745 · 2023: $1,953 · 2024: $628 · 2025: $97.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,925 · Travel and Lodging: $515 · Education: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,924.81 |
| Travel and Lodging | $514.76 |
| Education | $237.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $1,050.39 | 2021-2023 | Xeomin |
| Abbvie INC. | $533.01 | 2021-2025 | |
| Janssen Biotech, INC. | $397.79 | 2021-2024 | Tremfya, Simponi, Stelara |
| Galderma Laboratories, L.P. | $395.41 | 2021-2023 | |
| Amgen INC. | $237.74 | 2021-2023 | Otezla |
| Sun Pharmaceutical Industries INC. | $217.10 | 2021-2024 | Blu-U |
| Incyte Corporation | $205.33 | 2023-2024 | Opzelura |
| Lilly USA, LLC | $146.88 | 2021-2024 | Zepbound, Taltz, Olumiant |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2022-2024 | Spevigo |
| Janssen Scientific Affairs, LLC | $90.96 | 2022 | |
| Genentech USA, INC. | $87.44 | 2021-2024 | Erivedge |
| Revance Therapeutics, INC. | $82.38 | 2024-2025 | Daxxify |
| Arcutis Biotherapeutics, INC. | $70.95 | 2023 | |
| Pfizer INC. | $63.84 | 2021-2023 | |
| Ucb, INC. | $56.18 | 2022-2024 | Bimzelx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $45.28 | 2023-2024 | Sotyktu |
| Almirall LLC | $42.75 | 2022 | |
| Genzyme Corporation | $23.76 | 2022 | |
| Organogenesis INC. | $22.77 | 2024 | |
| Hologic Sales and Service, LLC | $19.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.